AstraGene Alternatives & Competitors
12 companies similar to AstraGene — Proteomics. Genomics. Therapeutics
Companies similar to AstraGene
KSL Biomedical
Proprietary applications in diagnostics and therapeutics. International technology develop...
IDEAYA Biosciences
Synthetic lethality precision medicine oncology company pursuing– an emerging class of pre...
Inoviv
Accelerating the Development of New Medicines with Targeted Proteomics
Navignostics AG
Finding the Right Drug for Each Patient
Track all AstraGene competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Inherent Biosciences, Inc.
Pioneering epigenetic medicine for complex diseases
anvajo
Lab diagnostics for everyone, everywhere.
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
InDevR, Inc.
InDevR is a global leader in progressive new analytical technologies for vaccines and othe...
Metamark Genetics
Metamark - A leader in comprehensive urology cancer care
IntegraGen
Company specializing in the genomics of cancer and genetic diseases
Adaptive Biotechnologies Corp.
Every immune system has a story to tell; the key is knowing how to listen.
About AstraGene
AstraGene is a biotechnology and manufacturing startup based in the United Arab Emirates. Founded in 2020, the company focuses on proteomics, genomics, and therapeutics, aiming to revolutionize the molecular diagnostics industry in the Middle East. With the slogan "Proteomics.
Proteomics, Genomics, Therapeutics, Molecular Diagnostics, Middle East, Precision Medicine
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches AstraGene and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at AstraGene on 13 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.